# Jon Trauben

> Jon Trauben is a Series A investor at Altitude Investment Management backing Cannabis. See 2 investments, check sizes, portfolio and contact details. Updated…

- Type: Angel Investor
- Fund: [Altitude Investment Management](https://shizune.co/investors/profile/altitude-investment-management)
- Total investments: 2
- Last investment: Sep 2019
- Lead investor: 50%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/in/jon-trauben-473867a/

Jon Trauben is a partner at Altitude Investment Management.

## Contacts

5 contacts available for Jon Trauben: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/jon-trauben?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 1 | 50% |
| Agriculture | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Market Research | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $7.5M | Series B | Sep 30, 2019 |  |
| PathogenDx | PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $3.4M | Series A | Jul 17, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [HALLEY Venture Partners](https://shizune.co/investors/profile/halley-venture-partners) — VC Fund, 2 deals together
- [Salveo Capital](https://shizune.co/investors/profile/salveo-capital) — VC Fund, 2 deals together
- [The Panther Opportunity Fund](https://shizune.co/investors/profile/the-panther-opportunity-fund) — VC Fund, 2 deals together
- [Arcadian Investment Partners](https://shizune.co/investors/profile/arcadian-investment-partners) — VC Fund, 1 deal together
- [Canopy Ventures](https://shizune.co/investors/profile/canopyventures) — VC Fund, 1 deal together
- [Cresco Capital Partners](https://shizune.co/investors/profile/cresco-capital-partners) — VC Fund, 1 deal together

## About Altitude Investment Management

VC Fund · New York, United States

Altitude is a New York-based venture capital fund manager focused on the global cannabis industry. The manager's strategy is to invest in a range of early to growth stage companies in North America and Europe that support this rapidly growing industry. Our principals have spent their careers launching and managing alternative investmentfunds, including distressed debt and leveraged credit strategies. We have been involved in highly-regulated industries for decades, and this experience makes our leadership team uniquely qualified to face the regulatory and funding challenges within the cannabis industry.Having invested in the cannabis industry for more than three years, Altitude has deep relationships with legal and regulatory professionals, CEOs of cannabis companies, industry organizations, and consultants.

5 contacts available at Altitude Investment Management.

| Name | Title | Profile |
| --- | --- | --- |
| Jon Trauben | Partner & Co-founder | https://shizune.co/investors/profile/jon-trauben |
| Christian Mark | Director of Marketing & Investor Relations | https://shizune.co/investors/profile/christian-mark-1322 |
| John Brecker | Partner | https://shizune.co/investors/profile/john-brecker |
| Michael Goldberg | Partner | https://shizune.co/investors/profile/michael-goldberg-451f |
| Roderick Stephan | Partner | https://shizune.co/investors/profile/roderick-stephan |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jon Trauben invest in?

Jon Trauben invests primarily in Cannabis, Agriculture and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Jon Trauben?

Public channels for Jon Trauben include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Jon Trauben last invest?

The most recent investment recorded for Jon Trauben closed in Sep 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co